Investment for health and wellbeing

Find out more about Oriola's Q1 2024

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Interim Report Q1 2024

Sales growth and improved profitability

Download Q1 report Download Q1 presentation Watch the webcast CEO blog

Annual Report 2023

Our Annual Report consists of the following sections: Business review, Sustainability report, Corporate governance statement, Remuneration report, Report of the Board of Directors and Financial statements.

Find out more

Shortcut to investor tools

Key figures Share information Shareholders

Latest stock exchange releases

30.04.2024 | Stock exchange releases

The Swedish Competition Authority prohibits Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB
25.04.2024 | Stock exchange releases

Oriola Corporation’s Interim Report January-March 2024
19.03.2024 | Stock exchange releases

Resolutions of the Annual General Meeting of Oriola Corporation and the decisions of the constitutive meeting of the Board of Directors
See all stock exchange releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts